Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Mitogen-activated protein kinase 14 | ||
Ligand | BDBM50347107 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_752994 (CHEMBL1798818) | ||
IC50 | 5±n/a nM | ||
Citation | Selness, SR; Boehm, TL; Walker, JK; Devadas, B; Durley, RC; Kurumbail, R; Shieh, H; Xing, L; Hepperle, M; Rucker, PV; Jerome, KD; Benson, AG; Marrufo, LD; Madsen, HM; Hitchcock, J; Owen, TJ; Christie, L; Promo, MA; Hickory, BS; Alvira, E; Naing, W; Blevis-Bal, R; Devraj, RV; Messing, D; Schindler, JF; Hirsch, J; Saabye, M; Bonar, S; Webb, E; Anderson, G; Monahan, JB Design, synthesis and activity of a potent, selective series of N-aryl pyridinone inhibitors of p38 kinase. Bioorg Med Chem Lett21:4059-65 (2011) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
Mitogen-activated protein kinase 14 | |||
Name: | Mitogen-activated protein kinase 14 | ||
Synonyms: | CSAID-binding protein | CSBP | CSBP1 | CSBP2 | CSPB1 | Cytokine suppressive anti-inflammatory drug-binding protein | MAP kinase 14 | MAP kinase MXI2 | MAP kinase p38 alpha | MAPK 14 | MAPK14 | MAX-interacting protein 2 | MK14_HUMAN | MXI2 | Mitogen-activated protein kinase p38 alpha | SAPK2A | Stress-activated protein kinase 2a | p38 MAP kinase alpha/beta | ||
Type: | Serine/threonine-protein kinase | ||
Mol. Mass.: | 41286.76 | ||
Organism: | Homo sapiens (Human) | ||
Description: | Q16539 | ||
Residue: | 360 | ||
Sequence: |
| ||
BDBM50347107 | |||
n/a | |||
Name | BDBM50347107 | ||
Synonyms: | CHEMBL1797210 | ||
Type | Small organic molecule | ||
Emp. Form. | C19H12BrF4NO3 | ||
Mol. Mass. | 458.201 | ||
SMILES | OCc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1c(F)cccc1F |(3.15,-8.82,;3.15,-10.36,;1.81,-11.13,;.48,-10.35,;-.85,-11.13,;-2.18,-10.36,;-3.52,-11.14,;-4.85,-10.37,;-6.17,-11.15,;-7.51,-10.39,;-7.52,-8.84,;-8.85,-8.08,;-6.18,-8.07,;-4.85,-8.83,;-3.51,-8.06,;-.85,-12.67,;-2.18,-13.44,;.48,-13.43,;.48,-14.97,;1.81,-12.67,;3.14,-13.44,;4.47,-12.67,;4.46,-11.13,;5.8,-13.44,;5.8,-14.99,;4.47,-15.75,;3.13,-14.98,;1.8,-15.75,)| | ||
Structure |